Baxter Strengthens Haemophilia Franchise with Chatham Therapeutics Purchase as Biogen Enters Market
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 5 (Table of Contents)
Published: 2 May-2014
DOI: 10.3833/pdr.v2014.i5.2023 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Baxter has agreed to acquire its partner Chatham Therapeutics in order to bolster its market-leading haemophilia franchise...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS